Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Depeng Li

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Nanoscale Horizons|March 5, 2020
Colloidal PbS quantum dot stacking kinetics during deposition via printingWei Chen, Haodong Tang, Nian Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2016
Busulfan Triggers Intrinsic Mitochondrial-Dependent Platelet Apoptosis Independent of Platelet ActivationJianlin Qiao, Yulu Wu, Yun Liu, et al.
Experimental and Therapeutic Medicine|August 18, 2018
Macrophages ameliorate bone marrow inflammatory injury and promote hematopoiesis in mice following hematopoietic stem cell transplantationJianlin Qiao, Lu Liu, Yuan Xia, et al.
Frontiers in Immunology|May 19, 2023
Prognostic value of prelymphodepletion absolute lymphocyte counts in relapsed/refractory diffuse large B-cell lymphoma patients treated with chimeric antigen receptor T cellsYanyan Lu, Hong Zhu, Yang Liu, et al.
International Journal of Hematology|October 16, 2014
Cdc42 inhibitor ML141 enhances G-CSF-induced hematopoietic stem and progenitor cell mobilizationChong Chen, Xuguang Song, Sha Ma, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2024
Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemiaSha Ma, Ying Wang, Kunming Qi, et al.
Bone Marrow Transplantation|May 11, 2020
Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairmentHujun Li, Lingling Yin, Ying Wang, et al.
Transplantation and Cellular Therapy|December 3, 2021
Absolute Lymphocyte Count Prior to Lymphodepletion Impacts Outcomes in Multiple Myeloma Patients Treated with Chimeric Antigen Receptor T CellsYang Liu, Wei Chen, Mingxiao Yu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2019
Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic MalignanciesYing Wang, Kunming Qi, Hai Cheng, et al.
Hematology (Amsterdam, Netherlands)|January 22, 2024
The prognostic significance of POD24 in peripheral T-cell lymphomaHuimin Chen, Ruixue Ma, Qianqian Zhang, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Nanoscale Horizons|March 5, 2020
Colloidal PbS quantum dot stacking kinetics during deposition via printingWei Chen, Haodong Tang, Nian Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2016
Busulfan Triggers Intrinsic Mitochondrial-Dependent Platelet Apoptosis Independent of Platelet ActivationJianlin Qiao, Yulu Wu, Yun Liu, et al.
Experimental and Therapeutic Medicine|August 18, 2018
Macrophages ameliorate bone marrow inflammatory injury and promote hematopoiesis in mice following hematopoietic stem cell transplantationJianlin Qiao, Lu Liu, Yuan Xia, et al.
Frontiers in Immunology|May 19, 2023
Prognostic value of prelymphodepletion absolute lymphocyte counts in relapsed/refractory diffuse large B-cell lymphoma patients treated with chimeric antigen receptor T cellsYanyan Lu, Hong Zhu, Yang Liu, et al.
International Journal of Hematology|October 16, 2014
Cdc42 inhibitor ML141 enhances G-CSF-induced hematopoietic stem and progenitor cell mobilizationChong Chen, Xuguang Song, Sha Ma, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2024
Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemiaSha Ma, Ying Wang, Kunming Qi, et al.
Bone Marrow Transplantation|May 11, 2020
Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairmentHujun Li, Lingling Yin, Ying Wang, et al.
Transplantation and Cellular Therapy|December 3, 2021
Absolute Lymphocyte Count Prior to Lymphodepletion Impacts Outcomes in Multiple Myeloma Patients Treated with Chimeric Antigen Receptor T CellsYang Liu, Wei Chen, Mingxiao Yu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2019
Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic MalignanciesYing Wang, Kunming Qi, Hai Cheng, et al.
Hematology (Amsterdam, Netherlands)|January 22, 2024
The prognostic significance of POD24 in peripheral T-cell lymphomaHuimin Chen, Ruixue Ma, Qianqian Zhang, et al.
Pageof 11